FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024017708> ?p ?o ?g. }

• W2024017708 endingPage "251" @default.
• W2024017708 startingPage "246" @default.
• W2024017708 abstract "Background & Aims Worldwide, about 180 million people are chronically infected with the hepatitis C virus (HCV). Current in vitro culture systems for HCV depend chiefly on human hepatoma cell lines. Although primary human hepatocytes support HCV infection in vitro, and immunodeficient mice repopulated with human hepatocytes support HCV infection in vivo, these models are limited because of shortage of human livers to isolate hepatocytes. Therefore, there is significant interest in the establishment from of a HCV culture system in human stem cell-derived hepatocyte-like cells. Methods Human embryonic stem cell (hESC)-derived hepatocytes were infected with HCV in the presence or absence of direct acting antivirals. After inoculation, replication of HCV was analyzed extensively. Results We demonstrate that hESC-derived hepatocytes can be infected with the HCV JFH1 genotype 2a, resulting in the production of viral RNA in the stem cell progeny. Viral replication is inhibited by a non-nucleoside HCV polymerase-inhibitor (HCV-796), a cyclophilin binding molecule (Debio 025-Alisporivir) and the protease inhibitor VX-950 (Telaprevir). Stem cell-derived hepatocytes produced, for more than 10 days, the HCV core protein as well as virions that were capable of re-infecting hepatoma cells. Conclusions Hepatocytes derived from hESC support the complete HCV replication cycle (including the production of infectious virus), and viral replication in these cells is efficiently inhibited by selective inhibitors of HCV replication. Worldwide, about 180 million people are chronically infected with the hepatitis C virus (HCV). Current in vitro culture systems for HCV depend chiefly on human hepatoma cell lines. Although primary human hepatocytes support HCV infection in vitro, and immunodeficient mice repopulated with human hepatocytes support HCV infection in vivo, these models are limited because of shortage of human livers to isolate hepatocytes. Therefore, there is significant interest in the establishment from of a HCV culture system in human stem cell-derived hepatocyte-like cells. Human embryonic stem cell (hESC)-derived hepatocytes were infected with HCV in the presence or absence of direct acting antivirals. After inoculation, replication of HCV was analyzed extensively. We demonstrate that hESC-derived hepatocytes can be infected with the HCV JFH1 genotype 2a, resulting in the production of viral RNA in the stem cell progeny. Viral replication is inhibited by a non-nucleoside HCV polymerase-inhibitor (HCV-796), a cyclophilin binding molecule (Debio 025-Alisporivir) and the protease inhibitor VX-950 (Telaprevir). Stem cell-derived hepatocytes produced, for more than 10 days, the HCV core protein as well as virions that were capable of re-infecting hepatoma cells. Hepatocytes derived from hESC support the complete HCV replication cycle (including the production of infectious virus), and viral replication in these cells is efficiently inhibited by selective inhibitors of HCV replication." @default.
• W2024017708 created "2016-06-24" @default.
• W2024017708 creator A5013918067 @default.
• W2024017708 creator A5026614780 @default.
• W2024017708 creator A5054691761 @default.
• W2024017708 creator A5056476810 @default.
• W2024017708 creator A5062640882 @default.
• W2024017708 creator A5065851031 @default.
• W2024017708 creator A5068457001 @default.
• W2024017708 creator A5080844718 @default.
• W2024017708 creator A5089010495 @default.
• W2024017708 date "2012-08-01" @default.
• W2024017708 modified "2023-10-06" @default.
• W2024017708 title "Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus" @default.
• W2024017708 cites W1970828145 @default.
• W2024017708 cites W1974593063 @default.
• W2024017708 cites W1977036616 @default.
• W2024017708 cites W1982230135 @default.
• W2024017708 cites W1986505810 @default.
• W2024017708 cites W1988173707 @default.
• W2024017708 cites W1994143142 @default.
• W2024017708 cites W2015489330 @default.
• W2024017708 cites W2018311444 @default.
• W2024017708 cites W2036761416 @default.
• W2024017708 cites W2044193462 @default.
• W2024017708 cites W2047604082 @default.
• W2024017708 cites W2062153657 @default.
• W2024017708 cites W2064546869 @default.
• W2024017708 cites W2075147482 @default.
• W2024017708 cites W2079608885 @default.
• W2024017708 cites W2088775687 @default.
• W2024017708 cites W2090712756 @default.
• W2024017708 cites W2127114188 @default.
• W2024017708 cites W2132046473 @default.
• W2024017708 cites W2140369033 @default.
• W2024017708 cites W2141214317 @default.
• W2024017708 cites W2149951088 @default.
• W2024017708 cites W2161890443 @default.
• W2024017708 cites W2167044622 @default.
• W2024017708 doi "https://doi.org/10.1016/j.jhep.2012.03.030" @default.
• W2024017708 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22521345" @default.
• W2024017708 hasPublicationYear "2012" @default.
• W2024017708 type Work @default.
• W2024017708 sameAs 2024017708 @default.
• W2024017708 citedByCount "91" @default.
• W2024017708 countsByYear W20240177082012 @default.
• W2024017708 countsByYear W20240177082013 @default.
• W2024017708 countsByYear W20240177082014 @default.
• W2024017708 countsByYear W20240177082015 @default.
• W2024017708 countsByYear W20240177082016 @default.
• W2024017708 countsByYear W20240177082017 @default.
• W2024017708 countsByYear W20240177082018 @default.
• W2024017708 countsByYear W20240177082019 @default.
• W2024017708 countsByYear W20240177082020 @default.
• W2024017708 countsByYear W20240177082021 @default.
• W2024017708 countsByYear W20240177082022 @default.
• W2024017708 crossrefType "journal-article" @default.
• W2024017708 hasAuthorship W2024017708A5013918067 @default.
• W2024017708 hasAuthorship W2024017708A5026614780 @default.
• W2024017708 hasAuthorship W2024017708A5054691761 @default.
• W2024017708 hasAuthorship W2024017708A5056476810 @default.
• W2024017708 hasAuthorship W2024017708A5062640882 @default.
• W2024017708 hasAuthorship W2024017708A5065851031 @default.
• W2024017708 hasAuthorship W2024017708A5068457001 @default.
• W2024017708 hasAuthorship W2024017708A5080844718 @default.
• W2024017708 hasAuthorship W2024017708A5089010495 @default.
• W2024017708 hasConcept C104317684 @default.
• W2024017708 hasConcept C107459253 @default.
• W2024017708 hasConcept C140704245 @default.
• W2024017708 hasConcept C145103041 @default.
• W2024017708 hasConcept C159047783 @default.
• W2024017708 hasConcept C2522874641 @default.
• W2024017708 hasConcept C2776408679 @default.
• W2024017708 hasConcept C2778159067 @default.
• W2024017708 hasConcept C2780040827 @default.
• W2024017708 hasConcept C28328180 @default.
• W2024017708 hasConcept C54355233 @default.
• W2024017708 hasConcept C81885089 @default.
• W2024017708 hasConcept C86803240 @default.
• W2024017708 hasConcept C95444343 @default.
• W2024017708 hasConceptScore W2024017708C104317684 @default.
• W2024017708 hasConceptScore W2024017708C107459253 @default.
• W2024017708 hasConceptScore W2024017708C140704245 @default.
• W2024017708 hasConceptScore W2024017708C145103041 @default.
• W2024017708 hasConceptScore W2024017708C159047783 @default.
• W2024017708 hasConceptScore W2024017708C2522874641 @default.
• W2024017708 hasConceptScore W2024017708C2776408679 @default.
• W2024017708 hasConceptScore W2024017708C2778159067 @default.
• W2024017708 hasConceptScore W2024017708C2780040827 @default.
• W2024017708 hasConceptScore W2024017708C28328180 @default.
• W2024017708 hasConceptScore W2024017708C54355233 @default.
• W2024017708 hasConceptScore W2024017708C81885089 @default.
• W2024017708 hasConceptScore W2024017708C86803240 @default.
• W2024017708 hasConceptScore W2024017708C95444343 @default.
• W2024017708 hasIssue "2" @default.
• W2024017708 hasLocation W20240177081 @default.
• W2024017708 hasLocation W20240177082 @default.
• W2024017708 hasOpenAccess W2024017708 @default.

• next